Cinclus Pharma Holding publ AB
STO:CINPHA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cinclus Pharma Holding publ AB
STO:CINPHA
|
SE |
|
Nature's Miracle Holding Inc
OTC:NMHI
|
US |
|
P
|
Premier Marketing PCL
SET:PM
|
TH |
|
Petards Group PLC
LSE:PEG
|
UK |
|
N
|
NGeneBio Co Ltd
KOSDAQ:354200
|
KR |
|
Nagano Bank Ltd
TSE:8521
|
JP |
|
T
|
TECOM Co Ltd
TWSE:2321
|
TW |
|
N
|
Navakij Insurance PCL
SET:NKI
|
TH |
|
I
|
IRIS Corporation Bhd
KLSE:IRIS
|
MY |
Wall St Price Targets
CINPHA Price Targets Summary
Cinclus Pharma Holding publ AB
According to Wall Street analysts, the average 1-year price target for CINPHA is 47.18 SEK with a low forecast of 25.25 SEK and a high forecast of 73.5 SEK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CINPHA's stock price target?
Price Target
47.18
SEK
According to Wall Street analysts, the average 1-year price target for CINPHA is 47.18 SEK with a low forecast of 25.25 SEK and a high forecast of 73.5 SEK.
What is the Revenue forecast for Cinclus Pharma Holding publ AB?
Projected CAGR
11%
Over the last 2 years, the compound annual growth rate for Revenue has been 211%. The projected CAGR for the next 3 years is 11%.